List of Excipients in Branded Drug ACITRETIN

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Prasco Laboratories	ACITRETIN	acitretin	66993-894	CELLULOSE, MICROCRYSTALLINE
Prasco Laboratories	ACITRETIN	acitretin	66993-894	FERRIC OXIDE RED
Prasco Laboratories	ACITRETIN	acitretin	66993-894	FERRIC OXIDE YELLOW
Prasco Laboratories	ACITRETIN	acitretin	66993-894	FERROSOFERRIC OXIDE
Prasco Laboratories	ACITRETIN	acitretin	66993-894	GELATIN

Generic Drugs Containing ACITRETIN

Company	Ingredient	NDC	Excipient
Teva Pharmaceuticals USA Inc	acitretin	0093-1135	CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc	acitretin	0093-1135	CROSPOVIDONE
Teva Pharmaceuticals USA Inc	acitretin	0093-1135	D&C YELLOW NO. 10
Teva Pharmaceuticals USA Inc	acitretin	0093-1135	D&C YELLOW NO. 10 ALUMINUM LAKE
Teva Pharmaceuticals USA Inc	acitretin	0093-1135	FD&C BLUE NO. 1

What are the Most Frequently-Used Excipients in ACITRETIN?

# Of NDCs	Excipient
1	AMMONIA
10	CELLULOSE, MICROCRYSTALLINE
1	CROSPOVIDONE
1	D&C YELLOW NO. 10
1	D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient Strategy and Commercial Opportunities for Acitretin

Last updated: February 27, 2026

What is the Role of Excipients in Acitretin Formulation?

Excipient selection for acitretin is vital for stability, bioavailability, and patient compliance. As a lipophilic drug, acitretin's poor water solubility necessitates specific formulation approaches. Key excipients include solubilizers, stabilizers, and carriers to enhance absorption and shelf life.

Primary Excipient Strategies

• Use of Oils and Lipids: Incorporation of medium-chain triglycerides (MCT oil) or other lipids improves drug solubilization in softgel capsules.
• Surfactants: Polysorbates or phospholipids increase dispersibility in aqueous environments, facilitating oral absorption.
• Antioxidants: Butylated hydroxytoluene (BHT) prevents oxidation, extending shelf life.

Formulation Technologies

• Softgel Capsules: Encapsulate acitretin dissolved in lipid-based excipients for enhanced bioavailability.
• Nanoparticle Systems: Lipid nanoparticles or nanoemulsions improve solubility and tissue penetration.
• Solid Dispersions: Use of hydrophilic carriers like polyvinylpyrrolidone (PVP) enhances dissolution.

Market Drivers for Excipient-Driven Acitretin Products

• Patient Compliance: Liquid formulations and softgels reduce dosing discomfort.
• Stability Concerns: Oxidative stability of acitretin influences excipient choice.
• Regulatory Compliance: Excipient sources and purity must meet stringent standards (EMA, FDA).

Commercial Opportunities in Excipient Innovation

Developing Novel Excipients

• Alternative Lipids: Plant-based or synthetic oils with superior stability could improve formulation performance.
• Custom Surfactants: Biotechnology-derived surfactants with enhanced safety profiles open markets in sensitive populations.
• Antioxidant Systems: Synergistic combinations can extend shelf life, especially in hot climates.

Partnership and Licensing

• Excipient Suppliers: Collaborate with manufacturers of high-purity lipids and surfactants.
• Contract Development: Outsource formulation R&D targeting improved bioavailability and stability.

Regulatory and Market Considerations

• Excipient patents are limited but critical; innovative excipients can carve competitive advantage.
• Market growth for dermatological drugs, including psoriasis and ichthyosis treatments, signals higher demand for optimized acitretin formulations.

Competitive Landscape

Major pharmaceutical companies invest in formulation enhancements to extend drug shelf life and improve patient adherence. Innovators focusing on combining excipient innovation with delivery systems gain differentiation.

Company	Focus Area	Notable Innovations
Roche	Lipid-based formulations	Lipid nanocarriers for dermatology
EffRx	Surfactant systems	Synthesis of novel surfactants
Patheon	softgel manufacturing	Custom lipid excipients

Key Commercial Opportunities

• Enhanced Bioavailability Formulations: Targeting unmet needs in bioavailability variability.
• Therapeutic Specialization: Developing formulations for specific populations (pediatrics, elderly).
• Geographic Expansion: Entering emerging markets with formulations tailored for local storage conditions.

Risks and Challenges

• Excipient Stability: Ensuring long-term stability in lipid-based systems.
• Regulatory Hurdles: Approval processes for novel excipients can delay commercialization.
• Cost Impact: Advanced excipient systems may increase manufacturing expenses.

Summary

Developing innovative excipient strategies for acitretin offers significant market potential. Focus areas include lipid-based formulations for improved bioavailability, stability-enhancing antioxidants, and bespoke surfactants. Strategic partnerships, regulatory navigation, and targeting emerging markets enhance commercial prospects.

---

Key Takeaways

• Excipient choice impacts acitretin's bioavailability, stability, and marketability.
• Lipid-based formulations are the primary approach for enhancing absorption.
• Novel excipients can provide differentiation but face regulatory and cost hurdles.
• Strategic collaborations with excipient suppliers and OEMs streamline development.
• Growing demand in dermatology markets supports expansion of optimized acitretin products.

---

FAQs

1. What excipients are critical for acitretin stability?
Antioxidants like BHT and lipid stabilizers prevent oxidation. Lipid carriers in formulations protect the drug and improve absorption.

2. Can excipient innovation extend acitretin shelf life?
Yes. Formulations utilizing antioxidant systems and stable lipid carriers can significantly prolong shelf life, especially under adverse storage conditions.

3. Are there regulatory constraints on novel excipients for acitretin?
Yes. Regulatory agencies require documentation of safety and efficacy. Novel excipients need prior approval or exemption pathways.

4. What formulation types best enhance acitretin bioavailability?
Lipid-based softgel capsules and nanoemulsions currently lead, offering improved dissolution and tissue penetration.

5. How does excipient strategy affect market expansion?
Optimized formulations with superior stability and bioavailability appeal to emerging markets and niche populations, driving sales growth.

---

References

1. Ghasemiyeh, P., & Mohammadi-Samani, S. (2020). Lipid-based formulations in pharmaceutical preparation: Advantages, challenges, and future perspectives. Drug Development and Industrial Pharmacy, 46(2), 317-330.
2. U.S. Food and Drug Administration. (2021). Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients.
3. European Medicines Agency. (2022). Reflection paper on formulation considerations for lipid nanocarriers.
4. Singh, S., et al. (2019). Advances in nanocarrier delivery for dermatological drugs. International Journal of Pharmaceutics, 567, 118457.
5. Bennett, D. (2021). Excipient patent landscape and strategic implications. Pharmaceutical Technology.